D

Dipna Pharmachem Ltd
BSE:543594

Watchlist Manager
Dipna Pharmachem Ltd
BSE:543594
Watchlist
Price: 11.61 INR -17.01%
Market Cap: ₹305.2m

Operating Margin

2.7%
Current
Improving
by 0.6%
vs 3-y average of 2.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.7%
=
Operating Income
₹34.2m
/
Revenue
₹1.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.7%
=
Operating Income
₹34.2m
/
Revenue
₹1.2B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Dipna Pharmachem Ltd
BSE:543594
279.2m INR
Loading...
US
Mckesson Corp
NYSE:MCK
102.5B USD
Loading...
US
Cencora Inc
NYSE:COR
68.5B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.6B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.8B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.5B AUD
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
65.3B CNY
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.6B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.1B USD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD
Loading...

Market Distribution

In line with most companies in India
Percentile
30th
Based on 5 437 companies
30th percentile
2.7%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Dipna Pharmachem Ltd
Glance View

Market Cap
305.2m INR
Industry
Health Care

Dipna Pharmaceuticals Ltd. engages in the trading and distribution of pharmaceutical raw material and chemical formulation products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-09-08. The firm's products include albendazole, ambroxol HCL, amisulpride IP/BP, amoxicillin aripiprazole IP, artemether, azithromycin, cefixime, carbamezapin, calcium gluconate IP, cefadroxyl monohydrate IP/BP/EP cephalexin, clindamycin phosphate IP/BP/USP, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine gluconate 20% solution, chlorhexidine hydrochloride, chlorhexidine acetate, dapoxetine HCL, dextromethorphan hydrobromic (DMR), diclofenac potassium, diclofenac sodium, dried alluminiumhydroxide IP, ferric ammounium citrate IP, ferrous ascorbate, folic acid IP, guaiphenesin IP, griseofulvin IP /BP, hydrocortisone acetate, ibuprofen IP, levofloxacin, lumefantrine, lidocaine base, lidocaine hydrochloride, lornoxicam, metronidazole plain/benzoate and mefenamic acid IP.

DPL Intrinsic Value
32.82 INR
Undervaluation 65%
Intrinsic Value
Price
D
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
2.7%
=
Operating Income
₹34.2m
/
Revenue
₹1.2B
What is Dipna Pharmachem Ltd's current Operating Margin?

The current Operating Margin for Dipna Pharmachem Ltd is 2.7%, which is above its 3-year median of 2.2%.

How has Operating Margin changed over time?

Over the last 2 years, Dipna Pharmachem Ltd’s Operating Margin has increased from 2.1% to 2.7%. During this period, it reached a low of 1.9% on Sep 30, 2024 and a high of 2.7% on May 1, 2025.

Back to Top